MRKR
Marker Therapeutics, Inc.Company with tickers: MRKR
CIK
1094038
CUSIP
57055L206
Shares Outstanding
16,673,127
13F Activity (30d)
3 filings
2 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-11-17 | Knobil Katharine |
Director | Award | 84,411 |
| 2025-11-17 | Knobil Katharine |
Director | Award | 137,330 |
| 2025-11-17 | Eansor Norman David |
Director | Award | 137,330 |
| 2025-11-17 | ELMS STEVE |
Director | Award | 84,411 |
| 2025-11-17 | Eansor Norman David |
Director | Award | 84,411 |
| 2025-11-17 | ELMS STEVE |
Director | Award | 137,330 |
| 2025-10-31 | Corzo Kathryn Penkus |
Director | Award | 147,611 |
| 2025-10-31 | Vera Juan |
Director | Award | 250,000 |
| 2025-10-31 | Corzo Kathryn Penkus |
Director | Other | 0 |
| 2025-02-12 | Vera Juan |
Director | Award | 50,000 |
| 2025-02-12 | ELMS STEVE |
Director | Award | 30,000 |
| 2025-02-12 | Eansor Norman David |
Director | Award | 30,000 |
| 2025-02-12 | Knobil Katharine |
Director | Award | 30,000 |
| 2024-12-23 | ELMS STEVE |
Director | Buy | 11,085 |
| 2024-12-23 | New Enterprise Associates 16, L.P. |
10% Owner | Buy | 554,250 |
| 2023-06-30 | Lurier Eliot M |
Interim CFO | Other | 0 |
| 2023-06-06 | Wilson John Robert |
Director | Award | 8,000 |
| 2023-06-06 | Knobil Katharine |
Director | Award | 8,000 |
| 2023-06-06 | ELMS STEVE |
Director | Award | 8,000 |
| 2023-06-06 | Eansor Norman David |
Director | Award | 8,000 |
| 2023-05-10 | Vera Juan |
Director | Award | 100,000 |
| 2023-02-27 | Koneru Mythili |
Chief Medical Officer | Award | 51,918 |
| 2023-02-27 | Loiacono Michael |
Chief Accounting Officer | Award | 38,480 |
| 2023-02-27 | Szymanska Anna |
Vice President, Quality | Award | 29,947 |
| 2023-02-27 | Hoang Tsvetelina P |
VP, Research and Development | Award | 33,159 |
| 2023-02-27 | Agopyan Nadia |
SVP, Regulatory Affairs | Award | 34,154 |
| 2023-02-27 | Vera Juan |
Director | Award | 46,487 |
| 2022-05-24 | Laskow-Pooley David |
Director | Award | 80,000 |
| 2022-05-24 | Knobil Katharine |
Director | Award | 80,000 |
| 2022-05-24 | ELMS STEVE |
Director | Award | 80,000 |
| 2022-05-24 | Wilson John Robert |
Director | Award | 80,000 |
| 2022-05-24 | Eansor Norman David |
Director | Award | 80,000 |
| 2022-03-24 | Hoang Peter L. |
Director, President and CEO | Award | 199,094 |
| 2022-03-24 | Kim Anthony H. |
Chief Financial Officer | Award | 150,512 |
| 2022-03-24 | Hoang Peter L. |
Director, President and CEO | Tax | 48,376 |
| 2022-03-24 | Kim Anthony H. |
Chief Financial Officer | Tax | 36,076 |
| 2022-03-24 | Vera Juan |
Director | Tax | 33,465 |
| 2022-03-24 | Vera Juan |
Director | Award | 140,823 |
| 2022-02-17 | Agopyan Nadia |
SVP, Regulatory Affairs | Award | 40,000 |
| 2022-02-17 | Garrett Gerald |
Vice President, Clinical Ops. | Award | 40,000 |
| 2022-02-17 | Kim Anthony H. |
Chief Financial Officer | Award | 160,000 |
| 2022-02-17 | Vera Juan |
Director | Award | 160,000 |
| 2022-02-17 | Szymanska Anna |
Vice President, Quality | Award | 40,000 |
| 2022-02-17 | Koneru Mythili |
Chief Medical Officer | Award | 160,000 |
| 2022-02-17 | Hoang Peter L. |
Director, President and CEO | Award | 430,000 |
| 2022-02-17 | Loiacono Michael |
Chief Accounting Officer | Award | 140,000 |
| 2022-02-17 | Hoang Tsvetelina P |
VP, Research and Development | Award | 40,000 |
| 2021-12-08 | Knobil Katharine |
Director | Award | 125,000 |
| 2021-06-08 | Wasserman Frederick Gerald |
Director | Award | 12,658 |
| 2021-06-08 | Eansor Norman David |
Director | Award | 12,658 |
Showing 1–50 of 103 transactions